CannaLean Biotechs Ltd., a clinical-stage biotechnology company developing a patented cannabidiol?chitosan (CBD?CHT) formulation for dyslipidemia, today announced the successful completion of its ...
Genezen, a leading gene therapy contract development and manufacturing organization (CDMO), and Atsena Therapeutics ("Atsena"), a clinical-stage gene therapy company focused on using the life-changing ...
Axsome Therapeutics focuses on CNS drug development as nasdaq today reflects activity across biopharmaceutical companies.
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback